血尿缓解改善IgA肾病的肾脏生存
该队列研究随访112例IgA肾病患者平均14年,发现持续性血尿者进展至ESRD或肾功能减半的风险显著高于血尿轻微或阴性者,血尿消失后肾功能下降速率显著减缓,提示血尿缓解对IgA肾病预后有有利影响。
要点
- 持续性血尿与IgA肾病患者ESRD或肾功能减半风险显著增加相关。
- 血尿消失后肾功能年下降速率显著减缓。
- 仅时间平均蛋白尿>0.75 g/d且持续血尿者肾脏生存显著更差。
核心结论
- 血尿缓解可能对IgA肾病结局有显著有利影响。
研究设计与样本
- 随访112例IgA肾病患者,平均±SEM随访14±10.2年,定期记录临床和分析风险因素包括尿沉渣检查。
主要发现
- 持续性血尿患者达到ESRD或肾功能下降50%的比例显著高于血尿轻微或阴性患者(30.4%和37.0% vs 10.6%和15.2%,P=0.01)。
- 多变量分析显示时间平均血尿、时间平均蛋白尿、基线肾功能和肾活检肾小管间质纤维化为ESRD的独立预测因素。
- 46%的患者血尿消失后,肾功能下降速率从-6.45±14.66变为-0.18±2.56 ml/min per 1.73 m2每年(P=0.001)。
- 时间平均蛋白尿>0.75 g/d者肾脏生存显著差于≤0.75 g/d者,但进一步分类后仅蛋白尿>0.75 g/d且持续血尿者肾脏生存显著差于其他三组。
临床怎么用
- 临床应重视IgA肾病患者血尿的监测与缓解,血尿持续存在提示更高进展风险。
- 对蛋白尿>0.75 g/d且持续血尿的患者应加强干预以改善肾脏生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hematuria is a cardinal symptom in IgA nephropathy, but its influence on the risk of disease progression has been scarcely investigated. We followed a cohort of 112 patients with IgA nephropathy for a mean±SEM period of 14±10.2 years, during which clinical and analytic risk factors (including urine sediment examination) were regularly recorded. According to the magnitude of time-averaged hematuria, we classified patients as those with persistent hematuria and those with negative or minimal hematuria. We also classified patients according to the magnitude of time-averaged proteinuria (>0.75 or ≤0.75 g/d). The proportion of patients reaching ESRD or a 50% reduction of renal function was significantly greater among patients with persistent hematuria than patients with minimal or negative hematuria (30.4% and 37.0% versus 10.6% and 15.2%, respectively; P=0.01). Multivariable analysis revealed time-averaged hematuria, time-averaged proteinuria, renal function at baseline, and the presence of tubulointerstitial fibrosis on renal biopsy as independent predictors of ESRD. After hematuria disappearance, which occurred in 46% of the patients, the rate of renal function decline changed from -6.45±14.66 to -0.18±2.56 ml/min per 1.73 m2 per year (P=0.001). Patients with time-averaged proteinuria >0.75 g/d had significantly poorer renal survival than those with time-averaged proteinuria ≤0.75 g/d. However, on further classification by time-averaged hematuria, only those patients with time-averaged proteinuria >0.75 g/d and persistent hematuria had significantly worse renal survival than those in the other three groups. In conclusion, remission of hematuria may have a significant favorable effect on IgA nephropathy outcomes.
引用
- Sevillano AM, Gutiérrez E, Yuste C, et al. Remission of Hematuria Improves Renal Survival in IgA Nephropathy. J Am Soc Nephrol. 2017. PMID: 28592423. doi:10.1681/ASN.2017010108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。